Circuit Clinical, a clinical research and technology company participating in the START-UP NY program, will create more than 100 new jobs and expand its operations in Buffalo, New York.

Through a strategic partnership with University at Buffalo’s Buffalo Institute for Genomics and Data Analytics, Circuit Clinical will create over 100 jobs for clinicians and technicians who will manage patients participating in hundreds of new clinical trials that Circuit Clinical will bring to Western New York.

UB BIG will invest $1.1 million over five years to support the company’s growth in Buffalo. The collaboration will enable more patients to participate in the clinical trials of drugs that could provide relief for their medical conditions. The advancement of the clinical trial process also expedites the process for drug approval by the Food and Drug Administration.

“Partnering with UB BIG helps us transform the patient experience in clinical research,” said Circuit Clinical CEO Jim Papineau. “By enhancing our software through our relationship with UB, we’ll personalize each patient’s participation in a way that hasn’t been done before. We’ll bring patients the latest research choices in the safety and convenience of the doctors’ offices they know and trust best. Our goal is to help bring new medicines to market faster and lower the costs of developing them.”

“Our administration is working to attract a new wave of talent and economic growth upstate and Western New York’s transformation continues to serve as a model of our progress,” Governor Andrew Cuomo said. “Circuit Clinical’s move to Buffalo will create jobs, generate economic opportunity and strengthen the region’s role as a leader in the future of medicine. This partnership is a metaphor for the new Buffalo and we will continue working together to build on our progress and continue moving Western New York forward.”

“This is a win-win,” said BIG Executive Director Brian McIlroy. “By combining the university’s assets with that of Circuit Clinical, we can cultivate a positive economic impact, while simultaneously enhancing clinical trial opportunities for the Buffalo Niagara region. UB, leveraging its Clinical and Translational Science Award (CTSA), is going to pilot Clinical Circuit’s software as it evaluates novel methods for improving clinical trials.”

“This is a perfect example of what START-UP NY brings to the table – an early-stage, innovative company collaborating with a world-class research institution to develop new science and create new jobs in New York State,” said Empire State Development President, CEO & Commissioner Howard Zemsky. “If it weren’t for START-UP NY and the better business climate Governor Cuomo has created, this fast-growing, high-tech medical company would have been on its way to another city or state, and taking more than 100 well-paying jobs with it.”